These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 20810603)
1. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Ladabaum U; Ferrandez A; Lanas A Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2765-76. PubMed ID: 20810603 [TBL] [Abstract][Full Text] [Related]
2. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare. Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand. Phisalprapa P; Supakankunti S; Chaiyakunapruk N J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness of screening for colorectal cancer in the general population. Frazier AL; Colditz GA; Fuchs CS; Kuntz KM JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892 [TBL] [Abstract][Full Text] [Related]
5. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study. Ladabaum U; Mannalithara A; Mitani A; Desai M Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population. Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918 [TBL] [Abstract][Full Text] [Related]
7. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population. Kim B; Lairson DR; Chung TH; Kim J; Shokar NK Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Sharaf RN; Ladabaum U Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579 [TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years. Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021 [TBL] [Abstract][Full Text] [Related]
10. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs. Ramsey SD; Wilschut J; Boer R; van Ballegooijen M Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066 [TBL] [Abstract][Full Text] [Related]
11. Cost Effectiveness of Screening Individuals With Cystic FibrosisĀ for Colorectal Cancer. Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616 [TBL] [Abstract][Full Text] [Related]
12. Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis. Ladabaum U; Scheiman JM; Fendrick AM Am J Med; 2003 May; 114(7):546-54. PubMed ID: 12753878 [TBL] [Abstract][Full Text] [Related]
13. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. van Hees F; Habbema JD; Meester RG; Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG Ann Intern Med; 2014 Jun; 160(11):750-9. PubMed ID: 24887616 [TBL] [Abstract][Full Text] [Related]
14. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists. Hassan C; Rex DK; Zullo A; Cooper GS Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430 [TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Current Colorectal Cancer Screening Tests. Ladabaum U Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):479-497. PubMed ID: 32439083 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score. Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186 [TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors. Gini A; Meester RGS; Keshavarz H; Oeffinger KC; Ahmed S; Hodgson DC; Lansdorp-Vogelaar I J Natl Cancer Inst; 2019 Nov; 111(11):1161-1169. PubMed ID: 30980665 [TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Ladabaum U; Mannalithara A Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of family history-based colorectal cancer screening in Australia. Ouakrim DA; Boussioutas A; Lockett T; Hopper JL; Jenkins MA BMC Cancer; 2014 Apr; 14():261. PubMed ID: 24735237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]